- Immediate angiography, rather than the standard CT scan, reduced time to stroke treatment.
- Stroke patients who were assessed with an immediate angiography had less disability at 90 days compared to those who received a CT scan.
Embargoed until 11 a.m. CT/12 p.m. ET Wednesday, March 17, 2021
(NewMediaWire) – March 17, 2021 – DALLAS – Immediate angiography, rather than the standard computed tomography (CT scan), reduced stroke treatment time and was linked to improved recovery, according to late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
Standard emergency department treatment for stroke patients involves a CT scan, which uses X-rays to pinpoint the presence and location of a blood clot. Angiography is an advanced X-ray imaging method that uses a catheter, or thin tube, inserted into the blood vessel to find the location and size of the blockage. Since every minute counts during a stroke, this study focused on determining if immediate angiography improved treatment time and recovery, compared to standard CT scans.
“Our study is the first clinical trial that shows the superiority of direct transfer to an angiography suite,” said lead study author Manuel Requena, Ph.D., a neurologist and neurointerventionalist fellow at Vall d’Hebron Hospital in Barcelona, Spain. “Our findings were close to what we expected, and we were surprised that they occurred so early in the study. We trust that they will be confirmed in ongoing, multicenter, international trials.”
Beginning in October 2018, stroke patients who were admitted to Vall d’Hebron Hospital within six hours of stroke symptom onset with a suspected blocked blood vessel were randomly assigned to receive angiography or a cardiac CT scan. There were a total of 150 stroke patients by November 2020; the average age of the patients was 73 years, and more than half were male.
In this interim analysis, stroke patients assigned to angiography underwent testing within 19 minutes of entering the hospital — less than half of the 43 minutes for the patients who received a CT scan. Similarly, stroke patients assigned to angiography received endovascular treatment to restore blood flow 54 minutes faster, on average, compared to CT scan recipients.
At 90 days post-stroke, angiography patients were more likely than CT scan patients to show a 1-point improvement on the 6-point scale that measures stroke disability.
“Stroke patients transferred directly to an angiography suite were less likely to be dependent for assistance with daily activities compared to the stroke patients who received the current standard of care – CT scan,” Requena said. “More frequent and more rapid treatment can help improve outcomes for our stroke patients.”
Many national and international professional organizations including the American Stroke Association have suggested general stroke recommendations based on the currently available evidence to monitor the time from emergency room arrival until blood flow is restored to the blocked brain artery in order to reduce the risk of severe disability and death. However, data demonstrating the urgent need for continued research on treatment of ischemic stroke is limited.
A limitation of this study is that the hospital already had extensive experience with immediate angiography, so findings may differ at hospitals or care centers with less angiography expertise or experience. Another limitation is that the results of the study were not monitored by an external review group.
According to the American Heart Association’s Heart Disease and Stroke Statistics — 2021 Update, when considered separately from other cardiovascular disease, stroke ranks No. 5 among all causes of death in the U.S., causing 147,810 deaths in 2018. Stroke occurs when a blood vessel to or in the brain either becomes blocked or bursts, preventing blood and oxygen from reaching all of the brain. Treatment to quickly restore blood flow to the brain is essential to improve outcomes and survival.
Co-authors are Marta Olivé-Gadea M.D.; Maria Ángeles Muchada, Ph.D.; David Hernández, M.D.; Marta Rubiera, Ph.D.; Sandra Boned, Ph.D.; Carlos Piñana, M.D.; Matías Deck, M.D.; Álvaro García-Tornel, M.D.; Humberto Díaz-Silva, M.D.; Noelia Rodríguez-Villatoro, Ph.D.; Jesús Maria Juega, M.D.; David Rodríguez-Luna, Ph.D.; Jorge Pagola, Ph.D.; Carlos Molina, Ph.D.; Alejandro Tomasello, M.D.; and Marc Ribo, Ph.D. The list of author disclosures is available in the abstract.
The study was funded by Vall d’Hebron Research Institute.
Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association’s overall financial information is available here.
The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2021 is virtual, March 17-19, 2021. This 3-day conference will feature more than 1,200 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences as they evolve toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies. Engage in the International Stroke Conference on social media via #ISC21.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit stroke.org. Follow us on Facebook, Twitter.
For Media Inquiries and ASA Expert Perspective: